185 related articles for article (PubMed ID: 32498019)
21. Free resources to assist structure-based virtual ligand screening experiments.
Villoutreix BO; Renault N; Lagorce D; Sperandio O; Montes M; Miteva MA
Curr Protein Pept Sci; 2007 Aug; 8(4):381-411. PubMed ID: 17696871
[TBL] [Abstract][Full Text] [Related]
22. ADMETopt: A Web Server for ADMET Optimization in Drug Design via Scaffold Hopping.
Yang H; Sun L; Wang Z; Li W; Liu G; Tang Y
J Chem Inf Model; 2018 Oct; 58(10):2051-2056. PubMed ID: 30251842
[TBL] [Abstract][Full Text] [Related]
23. Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1.
Mahajan P; Wadhwa B; Barik MR; Malik F; Nargotra A
Mol Divers; 2020 Feb; 24(1):45-60. PubMed ID: 30798436
[TBL] [Abstract][Full Text] [Related]
24. Modern drug discovery technologies: opportunities and challenges in lead discovery.
Guido RV; Oliva G; Andricopulo AD
Comb Chem High Throughput Screen; 2011 Dec; 14(10):830-9. PubMed ID: 21843147
[TBL] [Abstract][Full Text] [Related]
25. An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.
Becker OM; Dhanoa DS; Marantz Y; Chen D; Shacham S; Cheruku S; Heifetz A; Mohanty P; Fichman M; Sharadendu A; Nudelman R; Kauffman M; Noiman S
J Med Chem; 2006 Jun; 49(11):3116-35. PubMed ID: 16722631
[TBL] [Abstract][Full Text] [Related]
26. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
Langer T; Krovat EM
Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
[TBL] [Abstract][Full Text] [Related]
27. FungiPAD: A Free Web Tool for Compound Property Evaluation and Fungicide-Likeness Analysis.
Wang MY; Wang F; Hao GF; Yang GF
J Agric Food Chem; 2019 Feb; 67(7):1823-1830. PubMed ID: 30677302
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Potent Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 Using a Novel Growth-Based Protocol of
Liu Z; Singh SB; Zheng Y; Lindblom P; Tice C; Dong C; Zhuang L; Zhao Y; Kruk BA; Lala D; Claremon DA; McGeehan GM; Gregg RD; Cain R
J Chem Inf Model; 2019 Aug; 59(8):3422-3436. PubMed ID: 31355641
[TBL] [Abstract][Full Text] [Related]
29. Large-scale chemical similarity networks for target profiling of compounds identified in cell-based chemical screens.
Lo YC; Senese S; Li CM; Hu Q; Huang Y; Damoiseaux R; Torres JZ
PLoS Comput Biol; 2015 Mar; 11(3):e1004153. PubMed ID: 25826798
[TBL] [Abstract][Full Text] [Related]
30. De novo design - hop(p)ing against hope.
Schneider G
Drug Discov Today Technol; 2013 Dec; 10(4):e453-60. PubMed ID: 24451634
[TBL] [Abstract][Full Text] [Related]
31. MEDock: a web server for efficient prediction of ligand binding sites based on a novel optimization algorithm.
Chang DT; Oyang YJ; Lin JH
Nucleic Acids Res; 2005 Jul; 33(Web Server issue):W233-8. PubMed ID: 15991337
[TBL] [Abstract][Full Text] [Related]
32. Tracing binding modes in hit-to-lead optimization: chameleon-like poses of aspartic protease inhibitors.
Kuhnert M; Köster H; Bartholomäus R; Park AY; Shahim A; Heine A; Steuber H; Klebe G; Diederich WE
Angew Chem Int Ed Engl; 2015 Feb; 54(9):2849-53. PubMed ID: 25630461
[TBL] [Abstract][Full Text] [Related]
33. LEADOPT: an automatic tool for structure-based lead optimization, and its application in structural optimizations of VEGFR2 and SYK inhibitors.
Li GB; Ji S; Yang LL; Zhang RJ; Chen K; Zhong L; Ma S; Yang SY
Eur J Med Chem; 2015 Mar; 93():523-38. PubMed ID: 25743214
[TBL] [Abstract][Full Text] [Related]
34. Idea2Data: Toward a New Paradigm for Drug Discovery.
Nicolaou CA; Humblet C; Hu H; Martin EM; Dorsey FC; Castle TM; Burton KI; Hu H; Hendle J; Hickey MJ; Duerksen J; Wang J; Erickson JA
ACS Med Chem Lett; 2019 Mar; 10(3):278-286. PubMed ID: 30891127
[TBL] [Abstract][Full Text] [Related]
35. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.
Duffy BC; Zhu L; Decornez H; Kitchen DB
Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785
[TBL] [Abstract][Full Text] [Related]
36. Charting, navigating, and populating natural product chemical space for drug discovery.
Lachance H; Wetzel S; Kumar K; Waldmann H
J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
[TBL] [Abstract][Full Text] [Related]
37. The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design.
Cozza G
Pharmaceuticals (Basel); 2017 Feb; 10(1):. PubMed ID: 28230762
[TBL] [Abstract][Full Text] [Related]
38. Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase.
van Linden OP; Farenc C; Zoutman WH; Hameetman L; Wijtmans M; Leurs R; Tensen CP; Siegal G; de Esch IJ
Eur J Med Chem; 2012 Jan; 47(1):493-500. PubMed ID: 22137457
[TBL] [Abstract][Full Text] [Related]
39. Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.
Kéri G; Székelyhidi Z; Bánhegyi P; Varga Z; Hegymegi-Barakonyi B; Szántai-Kis C; Hafenbradl D; Klebl B; Muller G; Ullrich A; Erös D; Horváth Z; Greff Z; Marosfalvi J; Pató J; Szabadkai I; Szilágyi I; Szegedi Z; Varga I; Wáczek F; Orfi L
Assay Drug Dev Technol; 2005 Oct; 3(5):543-51. PubMed ID: 16305311
[TBL] [Abstract][Full Text] [Related]
40. Pharmacophore Mapping Approach for Drug Target Identification: A Chemical Synthesis and in Silico Study on Novel Thiadiazole Compounds.
Meshram RJ; Baladhye VB; Gacche RN; Karale BK; Gaikar RB
J Clin Diagn Res; 2017 May; 11(5):KF01-KF08. PubMed ID: 28658808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
